{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/051/SRR30068451/SRR30068451_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/055/SRR30068455/SRR30068455_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/059/SRR30068459/SRR30068459_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/053/SRR30068453/SRR30068453_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/057/SRR30068457/SRR30068457_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/053/SRR30068453/SRR30068453_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/060/SRR30068460/SRR30068460_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/056/SRR30068456/SRR30068456_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/050/SRR30068450/SRR30068450_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/059/SRR30068459/SRR30068459_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/058/SRR30068458/SRR30068458_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/049/SRR30068449/SRR30068449_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/052/SRR30068452/SRR30068452_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/054/SRR30068454/SRR30068454_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/056/SRR30068456/SRR30068456_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/054/SRR30068454/SRR30068454_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/051/SRR30068451/SRR30068451_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/050/SRR30068450/SRR30068450_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/052/SRR30068452/SRR30068452_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/055/SRR30068455/SRR30068455_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/049/SRR30068449/SRR30068449_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/058/SRR30068458/SRR30068458_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/057/SRR30068457/SRR30068457_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR300/060/SRR30068460/SRR30068460_1.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Sichuan University"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1142783"],"long_description":["To investigate whether intratumoral myeloid cells were trained, we sorted these cells and performed transcriptome sequencing."],"repository":["ENA"],"description_synonyms":["PD-1-PD-L1 Blockade, Nanoparticle, Memory, PD L1 Inhibitor, Materials, Innate Immunity, Node, Checkpoint Blockade, CTLA-4 Inhibitors, Process, Nanocrystalline Materials, Immunity, lymphatic system, Nanocrystalline, PD-1., glycans, Glykan, Checkpoint Inhibitor, Innate Trained Immunities, PD-L1 Inhibitors, Trained, PD 1 PD L1 Blockade, Innate Immune Memories, Nanocrystal, Memories, Glykane, Immune Memory, Cytotoxic T Lymphocyte Associated Protein 4 Inhibitors, CTLA 4 Inhibitors, polisacarido, Immune Checkpoint Blockers, Blockade, PD 1 Inhibitors, CTLA 4 Inhibitor, PD L1 Inhibitors, Programmed Cell Death Protein 1 Inhibitors, Trained Innate, PD-1 Inhibitor, Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitor, Polysaccharide, nodus lymphaticus, Lymph, polisacaridos, Immune Processes, Immune Responses, PD-1 Inhibitors, Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors, Glycans, Innate Immune, Lymph Node, Programmed Death-Ligand 1 Inhibitors, Immune Checkpoint Inhibitor, Innate Trained Immunity, Glycane, PD 1 Inhibitor, Programmed Cell Death Protein 1 Inhibitor, Checkpoint Blockers, Programmed Death Ligand 1 Inhibitors, polysaccharides, Cytotoxic T Lymphocyte Associated Protein 4 Inhibitor, Trained Innate Immunity, CTLA-4 Inhibitor, Immune Checkpoint Blockade, Trained Immunities, Lymph node, Immune Response, Immune, Material, Checkpoint Inhibition, PD-L1 Inhibitor, Trained Immunity, Glycan, Innate Immune Memory, Nodes, Trained Innate Immunities, Response, PD-1-PD-L1, Nanocrystals, lymph gland, Checkpoint Inhibitors, Immune Memories, Immune Process, Innate, Inhibitor, Immune Checkpoint Inhibition, Nanocrystalline Material"],"additional_accession":[]},"is_claimable":false,"name":"","description":"Polysaccharide nanoparticles initiate trained immunity through lymph node immune responses and synergistically eradicate tumours with innate immune checkpoint blockade","dates":{"last_updated":"2024-08-03","first_public":"2024-08-03"},"accession":"PRJNA1142783","cross_references":{}}